Therefore, endothelial CAT1 overexpression and subsequent increases in NO bioavailability may prevent obesity-induced hypertension, at least in part, by reducing the sympathetic contribution to hypertension. The gene discussed is SLC7A1; the disease is obesity due to melanocortin 4 receptor deficiency.